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ABSTRACT
Rotavirus infection is a major cause of severe dehydrating diarrhea in infants younger than 5 y old
and in particular cases of immunocompromised patients irrespective to the age of the patients.
Although vaccines have been developed, antiviral therapy is an important complement that cannot
be substituted. Because of the lack of speciﬁc approved treatment, it is urgent to facilitate the
cascade of further understanding of the infection biology, identiﬁcation of druggable targets and
the ﬁnal development of effective antiviral therapies. PI3K-Akt-mTOR signaling pathway plays a vital
role in regulating the infection course of many viruses. In this study, we have dissected the effects
of PI3K-Akt-mTOR signaling pathway on rotavirus infection using both conventional cell culture
models and a 3D model of human primary intestinal organoids. We found that PI3K-Akt-mTOR
signaling is essential in sustaining rotavirus infection. Thus, blocking the key elements of this
pathway, including PI3K, mTOR and 4E-BP1, has resulted in potent anti-rotavirus activity.
Importantly, a clinically used mTOR inhibitor, rapamycin, potently inhibited both experimental and
patient-derived rotavirus strains. This effect involves 4E-BP1 mediated induction of autophagy,
which in turn exerts anti-rotavirus effects. These results revealed new insights on rotavirus-host






Rotavirus is a member of the Reoviridae family.1 As the
leading cause of severe dehydrating diarrhea, it mainly
attacks children younger than 5 y old, resulting in
approximate 114 million diarrheal episodes and 453,000
infant deaths annually.2,3 Besides children, accumulating
evidences indicate that rotavirus could also cause chronic
infection in organ transplantation patients, irrespective
to the age of the patients.4-6 Although 2 safe licensed vac-
cines named RotaTeq (Merck and Co., PA, USA) and
Rotarix (GSK Biologicals, Rixensart, Belgium) are avail-
able,1 the implementation of these vaccines in many
developing countries remains challenge due to high cost
and logistic issues.7 Since no approved medication is
available, the development of effective antiviral therapies
is indispensable to combat this pathogen.
Numerous signaling pathways play important roles in
regulating virus infection either by supporting or defend-
ing the infection of virus.8 Phosphatidylinositol 3-kinase
(PI3K)-protein kinase B (Akt)-mammalian target of
rapamycin (mTOR) axis takes a vital part in regulating
various cellular functions and biologic processes, includ-
ing protein synthesis, cell cycle progression, cell survival,
apoptosis, angiogenesis and drug resistance.9 In this sig-
naling, PI3K serves as a key node, which is capable of
monitoring panels of biologic processes via phosphoryl
transfer.10 PI3K could be activated by many types of cel-
lular stimuli, which subsequently phosphorylates the
inositol PIP2 to PIP3 that recruits Akt to the plasma
membrane by binding to its N-terminal pleckstrin
homology (PH) domain in which Akt gets activation
via phosphorylation.11 As a serine/threonine kinase,
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phosphorylated Akt is able to stimulate mTOR which
belongs to a member of the serine/threonine phosphati-
dyl inositol 30 kinase-related kinase family (PIKK).10
mTOR is an evolutionarily conserved Serine/
Threonine kinase playing indispensable roles in regu-
lating mRNA translation, autophagy machinery and
cell proliferation.12 Furthermore, mTOR can directly
activate a variety of cellular effectors such as p70S6
kinase (p70S6K) and eukaryotic translation initiation
factor 4E-binding protein 1 (4E-BP1) to control cell
growth through integrating nutritional information
and receptor tyrosine kinase signaling.13 For instance,
mTOR controls capped-dependent translation of both
cells and viruses via inducing phosphorylation of
4E-BP1 to promote the formation of a functional
eukaryotic initiation factor 4F (eIF-4F) complex.12,14
The eIF-4F complex comprises 3 subunits including a
RNA helicase eIF4A, a cap-binding protein eIF4E and
a scaffolding protein eIF4G.15 Most of the 4E-BPs
share a canonical eIF4E-binding motif (4E-BM) of
sequence YX4LF with eIF4G (where Y denotes Tyr,
X denotes any amino acid, L denotes Leu, and F
denotes a hydrophobic residue). But some 4E-BPs
contain non-canonical 4E-BMs connected by a linker
(15–30 residues), and the motifs are not conserved
and not required for eIF4G binding.15 Autophagy
machinery, as another important downstream element
of the mTOR signaling, is a cellular non-speciﬁc, bulk
degradation process involved in removing damaged
macromolecules and organelles to defend nutrient
and environmental stress,16,17 which is also involved
in regulating virus infection.18
PI3K-Akt-mTOR pathway as a potential antiviral
target is involved in the infection of a broad spectrum
of viruses including lymphocytic choriomeningitis
virus (LCMV),19 Middle East Respiratory Syndrome
Coronavirus (MERS-CoV),20 HIV 21 and human cyto-
megalovirus.22 In this study, we comprehensively
studied the role of PI3K-Akt-mTOR signaling in
rotavirus infection and explored the avenues of thera-
peutic targeting. Besides conventional 2 dimension
(2D) culture based immortalized cells, we also used 3
dimension (3D) cultures of primary human intestinal
organoids for modeling rotavirus infection.23 These
organoids can recapitulate most if not all aspects of
in vivo tissue architecture of intestinal epithelium.24
We found that PI3K-Akt-mTOR pathway is crucial in
sustaining rotavirus infection via its downstream
effector 4E-BP1 and the induction of autophagy.
Importantly, targeting this pathway by pharmacologi-
cal inhibitors/FDA approved drugs potently inhibited
rotavirus infection, providing novel therapeutic
approaches for combating this virus.
Results
Inhibition of PI3K signaling potently inhibits
rotavirus
Since PI3K serves as a key node in the PI3K-Akt-mTOR
pathway, its effect on rotavirus was tested. LY294002 is a
potent inhibitor of PI3K. In human Caco2 cells, treat-
ment with 5 mM LY294002 potently inhibited phosphor-
Ser-240/244 S6 and phosphor-4E-BP1 (T70) but not the
corresponding total proteins (as controls) (Fig. 1A and
Figure S1A). Importantly, treatment with 1 and 5 mM
LY294002 for 48 h resulted in 93.5 § 1.7% (n D 4;
P < 0.05) and 81.0 § 6.8% (n D 4; P < 0.05) reduction
of viral RNA, respectively (Fig. 1B). LY294002 could
also signiﬁcantly suppress rotavirus RNA secretion
(Figure S2B). The inhibitory effect of this compound was
further veriﬁed by TCID50 method, demonstrating that it
could remarkably inhibit the production of infectious
viral particles (Fig. 1C). Western blot assay further con-
ﬁrmed that treatment with 0.1, 1 and 5 mM LY294002
could vigorously inhibit rotavirus protein synthesis in
Caco2 cells (Fig. 1D). The effect of this drug was also
validated in human primary intestinal organoids. Immu-
noﬂuorescent staining showed that phosphor-Ser-240/
244 S6 was potently inhibited by treatment of 5 mM
LY294002 (Fig. 1E), supporting that human intestinal
organoid is also a PI3K signaling proﬁcient model.
Consistently, LY294002 inhibited rotavirus infection in
organoid model. For instance, 5 mM LY294002 resulted
in 86.0 § 6.4% (n D 4; P < 0.05) reduction of viral RNA
in human intestinal organoids (Fig. 1F). Thus, blocking
PI3K by LY294002 potently inhibits rotavirus infection
in both Caco2 cells and human intestinal organoids.
mTOR sustains rotavirus infection and the mTOR
inhibitor rapamycin inhibits its infection
mTOR is a central element of the PI3K-Akt-mTOR
signaling pathway, we thus investigated its effect on rota-
virus infection. To address this, Caco2 cells were trans-
duced with integrating lentiviral vectors expressing
shRNA to silence mTOR. One (No 8198) out of 3 clones
showed potent knockdown based on western blot results
(Fig. 2A), which was also conﬁrmed by qRT-PCR
(Fig. 2B). Caco2 cells with mTOR knockdown or
scrambled shRNA (as control) were inoculated with SA11
rotavirus and viral genomic RNA was quantiﬁed by qRT-
PCR 48 h post inoculation. Silencing of mTOR led to a
signiﬁcant reduction of rotavirus RNA (Fig. 2C), suggest-
ing a supportive role of mTOR for rotavirus infection.
Rapamycin is a clinically used mTOR inhibitor, and it
was approved by FDA to treat/prevent transplant allograft
rejection.25 Phosphorylation of Ser-2448 mTOR, Ser-240/
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244 S6 and 4E-BP1 (T70) but not for the corresponding
total proteins (as controls) were inhibited by treatment
with 1, 5 and 10 nM rapamycin for 48 h in Caco2 cells
(Fig. 3A and Figure S1B), except for phosphorylation of
Ser-473 Akt. mTOR/S6K inhibition by rapamycin was
reported to trigger a negative feedback loop to activate
Akt signaling,26 which might be the reason that
rapamycin had minor inhibitory effect on phosphorylated
Akt. Furthermore, treatment of 5 and 10 nM rapamycin
signiﬁcantly inhibited viral genomic RNA by 80.0 § 5.5%
(n D 8; P < 0.01) and 79.9 § 5.8% (n D 9; P < 0.01) in
Caco2 cells, respectively (Fig. 3B). Rotavirus RNA secre-
tion (Figure S2C) and infectious virus production
(Fig. 3C) were also signiﬁcantly inhibited by treatment of
Figure 1. Inhibition of PI3K signaling potently inhibits rotavirus infection. (A) Western blot analysis of p-mTOR (S2448), t-mTOR, p-Akt
(S473), p-S6 (S240/244) and p-4E-BP1 (T70) protein levels and the corresponding total protein levels under the treatment of indicated
concentrations of LY294002 (48 h) in Caco2 cells. (B) Treatment with LY294002 (48 h) potently inhibited viral genomic RNA in SA11 rota-
virus infected Caco2 cells measured by qRT-PCR (n D 4, mean § SEM, P < 0.05, Mann-Whitney test). (C) Effects of LY294002 on the
production of infectious viral particles determined by TCID50 method. Each bar represents the TCID50/mL (mean § SEM) (n D 5,P < 0.05, P < 0.01, Mann-Whitney test). (D) Treatment with LY294002 (48 h) potently inhibited viral VP4 protein in SA11 rotavirus
infected Caco2 cells determined by western blot assay. (E) Representative confocal immunostainings of p-S6 (S240/244) (Green) after
48 h incubation with 0 (as control) and 5 mM LY294002 in human intestinal organoids. Nuclei were visualized by DAPI (blue). (F) Treat-
ment with LY294002 (48 h) signiﬁcantly inhibited viral genomic RNA in SA11 rotavirus infected human intestinal organoids examined
by qRT-PCR (n D 4, mean § SEM, P < 0.05, Mann-Whitney test).
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rapamycin. Consistently, western blot assay indicated that
rotavirus VP4 protein synthesis was potently inhibited by
rapamycin treatment (Fig. 3D). In contrast, rapamycin
lost its anti-rotavirus activity in mTOR silenced Caco2
cells (Fig. 3E), supporting its speciﬁcity in inhibiting its
biologic target to exert the antiviral action.
To verify the anti-rotavirus effect of rapamycin,
human intestinal organoids infected with SA11 rotavirus
were treated with 10 or 100 nM rapamycin for 48 h,
which led to vigorous inhibition of phosphor-Ser-240/
244 S6 (Fig. 3F). Importantly, 10 nM rapamycin resulted
in a signiﬁcant reduction (75.9 § 5%, n D 5; P < 0.01) of
viral RNA replication (Fig. 3G). This was further vali-
dated in 5 patient-derived strains by inoculation of
Caco2 cells or human intestinal organoids with stool
samples from rotavirus-infected patients (Table S2).
Treatment with 10 nM rapamycin inhibited patient-
derived isolates in both Caco2 cells (Fig. 3H) and human
intestinal organoids (Fig. 3I). These results have demon-
strated that efﬁcient infection of rotavirus requires
mTOR, but the infection can be effectively inhibited by
rapamycin.
Dual inhibition of PI3K and mTOR inhibits rotavirus
infection
BEZ235 is a pharmacological dual inhibitor of PI3K and
mTOR. Western blot conﬁrmed that this compound
could potently inhibit phosphorylation of Ser2448
mTOR, 70S6K (T389), Ser473 Akt, Ser240/244 S6 and
4E-BP1 (T70) but not for the corresponding total pro-
teins (as controls) in Caco2 cells (Fig. 4A and
Figure S1C). Importantly, BEZ235 dose-dependently
inhibited viral RNA (Fig. 4B) and RNA secretion in
Caco2 cells (Figure S2D). Using the TCID50 method, we
have demonstrated that it remarkably inhibits the pro-
duction of infectious viral particles (Fig. 4C). BEZ235
was also capable of inhibiting synthesis of rotavirus VP4
protein (Fig. 4D). This effect was also conﬁrmed in
human intestinal organoids of inhibiting phosphoryla-
tion of Ser240/244 S6 (Fig. 4E) and rotavirus infection
(Fig. 4F). Although rotavirus infection did not directly
affect the expression levels of the key components the
PI3K-Akt-mTOR pathway (Figure S3), this pathway
itself intrinsically sustained rotavirus infection.
4E-BP1, but not S6K, is a downstream effector
of mTOR in sustaining rotavirus infection
4E-BP1 is one of the important downstream elements of
PI3K-Akt-mTOR signaling. We ﬁrst studied its potential
involvement by lentiviral RNAi mediated loss-of-func-
tion assay (Fig. 5A and Figure S1D). Caco2 cells with the
best knockdown of 4E-BP1 (no 6463) resulted in 62.4 §
6.1% (n D 5, P <0.01) reduction of SA11 rotavirus viral
RNA 48 h post-inoculation (Fig. 5B). Consistently, the
anti-rotavirus effect of rapamycin was abolished in 4E-
BP1 knockdown cells conﬁrmed by both qRT-PCR assay
(Fig. 5C) and western blot assay (Fig. 5D). To further
verify, we obtained 4E-BP1 knockout mouse embryonic
ﬁbroblasts (MEFs), and bona ﬁde knockout was
Figure 2. Silence of mTOR inhibits rotavirus replication. (A)
Western blot analysis of t-mTOR, p-S6 (S240/244), t-S6, p-4E-BP1
(T70) and t-4E-BP1 (53H11) protein in lentiviral RNAi against
mTOR transduced Caco2 cells. (B) One (No. 8198) of 3 lentiviral
shRNA vectors showed successful knockdown determined by
qRT-PCR (n D 9, mean § SEM, P < 0.001, Mann-Whitney
test). (C) mTOR knockdown inhibited rotavirus genomic RNA
determined by qRT-PCR (n D 7, mean § SEM, P < 0.05, Mann-
Whitney test).
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conﬁrmed by western blot assay (Fig. 5E). Consistently,
rotavirus infection in 4E-BP1 knockout MEFs (¡/¡) is
signiﬁcantly less efﬁcient (75.1 § 17.2%; n D 4; P <
0.05), compared with the infection in wild type MEFs
(C/C) (Fig. 5F). Furthermore, the anti-rotavirus effect of
rapamycin was attenuated in 4E-BP1 knockout MEFs
(Fig. 5G). Consistently, rapamycin could inhibit rotavi-
rus replication in 4E-BP1 KO MEFs transfected with
Figure 3. Rapamycin inhibits replication of SA11 and patient-derived rotavirus replication. (A) Western blot analysis of p-mTOR (S2448),
t-mTOR, p-Akt (S473), t-Akt, p-S6 (S240/244), t-S6, p-4E-BP1 (T70) and t-4E-BP1 (53H11) protein levels with the treatment of indicated
concentrations of rapamycin in Caco2 cells. (B) Treatment with rapamycin (48 h) signiﬁcantly inhibited SA11 rotavirus replication in
Caco2 cells (n D 7–9, mean § SEM, P < 0.01, Mann-Whitney test). (C) Effects of rapamycin on the production of infectious viral par-
ticles determined by TCID50 method. Each bar represents the TCID50/mL (mean § SEM) (n D 5, P < 0.05, P < 0.01, Mann-Whitney
test). (D) Treatment with rapamycin (48 h) inhibited viral VP4 protein determined by western blot assay in Caco2 cells. (E) Anti-rotavirus
effect of rapamycin was abolished in mTOR knockdown Caco2 cells (n D 10, mean § SEM, P < 0.05, Mann-Whitney test). (F) Represen-
tative confocal immunostainings of p-S6 (S240/244) (Green) after 48 h treatment with 10 and 100 nM rapamycin in human intestinal
organoids. Nuclei were visualized by DAPI (blue). (G) Treatment with rapamycin (48 h) inhibited SA11 rotavirus genomic RNA in human
intestinal organoids determined by qRT-PCR (n D 5, mean § SEM, P < 0.01, Mann-Whitney test). (H) Treatment with 10 nM rapamycin
(48 h) inhibited patient-derived rotavirus (isolate 1–5) genomic RNA in Caco2 cells determined by qRT-PCR. (I) Treatment with rapamy-
cin (48 h) inhibited patient-derived rotavirus (isolate 1–5) genomic RNA in human intestinal organoids determined by qRT-PCR.
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4E-BP1 wild-type (4E-BP1-WT) plasmids; while this
antiviral effect was abolished in 4E-BP1 KO MEFs trans-
fected with 4E-BP1 plasmids having 5 mutations of the
phosphorylation sites (4E-BP1–5A) (Fig. 5H). Of note,
the inhibitor of S6K did not affect rotavirus infection
(Figure S4). Collectively, these data suggest that 4E-BP1
but not S6K is a downstream effector of the PI3K-
Akt-mTOR signaling in sustaining rotavirus infection.
Figure 4. Dual inhibition of PI3K and mTOR inhibits rotavirus infection. (A) Western blot assay detected p-mTOR (S2448), p-p70S6K
(T389), p-Akt (S473) and p-S6 (S240/244) and the corresponding total proteins after 48 h incubation with indicated concentrations of
BEZ235 in Caco2 cells. (B) Treatment with BEZ235 (48 h) signiﬁcantly inhibited SA11 rotavirus genomic RNA in dose-dependent-manner
determined by qRT-PCR in Caco2 cells (n D 5, mean § SEM, P < 0.05, Mann-Whitney test). (C) Effects of BEZ235 on the production of
infectious viral particles determined by TCID50 method. Each bar represents the TCID50/mL (mean § SEM) (n D 5, P < 0.05, P < 0.01,
Mann-Whitney test). (D) Western blot showed that treatment with BEZ235 (48 h) signiﬁcantly inhibited SA11 rotavirus VP4 protein in
Caco2 cells. (E) Representative confocal immunostainings of p-S6 (S240/244) (Green) after 48 h incubation with 0 (as a control) and
10 nM BEZ235 in human intestinal organoids. Nuclei were visualized by DAPI (blue). (F) Treatment with BEZ235 (48 h) signiﬁcantly inhib-
ited SA11 rotavirus genomic RNA in human intestinal organoids quantiﬁed by qRT-PCR (n D 11, mean § SEM, P < 0.01, Mann-
Whitney test).
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Figure 5. 4E-BP1 is a downstream effector of PI3K-Akt-mTOR signaling in sustaining rotavirus infection. (A) Western blot assay
detected t-Akt and t-4E-BP1 (53H11) in lentiviral RNAi against 4E-BP1 transduced Caco2 cells. (B) Knockdown of 4E-BP1 signiﬁ-
cantly inhibited SA11 rotavirus genomic RNA quantiﬁed by qRT-PCR (n D 5, mean § SEM, P < 0.05, Mann-Whitney test). (C)
Anti-rotavirus effect of rapamycin (10 nM) was abolished in 4E-BP1 knockdown Caco2 cells (n D 5, mean § SEM, P < 0.05,
P < 0.01, Mann-Whitney test). (D) Western blot assay conﬁrmed that anti-rotavirus effect of rapamycin (10 nM) was abolished
in 4E-BP1 knockdown Caco2 cells. (E) Western blot indicated bona ﬁde knockdown of 4E-BP1 in knockout (¡/¡) MEF cells. (F)
SA11 rotavirus replication was potently restricted in 4E-BP1 knockout (¡/¡) MEF cells (n D 4, mean § SEM, P < 0.05, Mann-
Whitney test). (G) Anti-rotavirus effect of rapamycin (10 nM) was attenuated in 4E-BP1 knockout (¡/¡) MEF cells (n D 8, mean
§ SEM, P < 0.05, Mann-Whitney test). (H) Rapamycin inhibited rotavirus replication in 4E-BP1 KO MEFs transfected with
4E-BP1-WT plasmids; while this antiviral effect was abolished in 4E-BP1 KO MEFs transfected with 4E-BP1–5A plasmids (n D 5,
mean § SEM, P < 0.05, Mann-Whitney test).
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Figure 6. 4E-BP1 mediates rapamycin-induced autophagy that inhibits rotavirus infection. (A) Caco2 cells transduced with lentiviral par-
ticles carrying a construct of TagGFP2-LC3 driven by the elongation factor-1 promotor were cultured at 37C for 48 h in DMEM medium
containing EBSS medium containing 1mM pepstatin A and E-64-d solution (for starvation) and 10 nM rapamycin. LC3-positive puncta
was observed by confocal laser microscopy. (B) LC3-I and LC3-II protein levels were examined by western blot analysis. Protein samples
were extracted from Caco2 cells treated with indicated concentrations of rapamycin (48 h). Quantiﬁcation of the intensity of the immu-
noreactive bands of both LC3-I and LC3-II was performed using Odyssey V3.0 software. Densitometric analysis of immunoblots of LC3
was expressed as the ratio of LC3-II to LC3-I, and the ratio of LC3II/LC3I was expressed in arbitrary units. (C) Western blot visualized
LC3-I and LC3-II protein levels in starvation (EBSS medium containing 1mM pepstatin A and E-64-d solution) treated Caco2 cells. The
ratio of LC3II/LC3I was expressed in arbitrary units. (D) Starvation signiﬁcantly inhibited rotavirus RNA in Caco2 cells (n D 6, mean §
SEM, P < 0.05, Mann-Whitney test). (E) Starvation dramatically inhibited rotavirus protein VP4 synthesis in Caco2 cells. (F) Rapamycin
induced autophagy in 4E-BP1 KO MEFs transfected with 4E-BP1-WT plasmids; while the induction was abolished in 4E-BP1 KO MEFs
transfected with 4E-BP1–5A plasmids. (G) Western blot demonstrated that upregulated ratio of LC3-II to LC3-I by rapamycin was abol-
ished in 4E-BP1 knockout (¡/¡) MEFs (n D 6, mean § SEM, P < 0.05, P < 0.01, Mann-Whitney test). (H) Western blot detected that
upregulated ratio of LC3-II to LC3-I by starvation (EBSS medium containing 1mM pepstatin A and E-64-d solution) was abolished in
4E-BP1 knockout (¡/¡) MEFs (n D 5, mean § SEM, P < 0.05, Mann-Whitney test).
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4E-BP1 mediates rapamycin-induced autophagy that
inhibits rotavirus infection
Previous studies have reported that rapamycin or 4E-
BP1 may affect type I IFN signaling,27-29 in particular the
downstream antiviral proteins including interferon regu-
latory factor 1 (IRF1) and IRF7. Furthermore, we previ-
ously have reported the anti-rotavirus effect of IFNa.23
We thus investigated whether these antiviral proteins
may play a role in this setting. We found that rapamycin
treatment did not affect the protein expression of IRF1
or IRF7 in Caco2 cells and MEFs (Figure S5A and B).
Although the deﬁciency of 4E-BP1 appears to slightly
increase IRF7 but not IRF1 protein synthesis
(Figure S5B). Thus, these results indicate that these anti-
viral proteins are likely not essential in the anti-rotavirus
action of the PI3K-Akt-mTOR signaling.
We therefore redirected our attention to autophagy, a
cellular metabolism process functioning in orderly deg-
radation and recycling of cellular components, which
has been implicated in regulating many types of virus
infections.30 mTOR is the main inhibitor of autophagy.
Rapamycin, as a speciﬁc inhibitor of mTOR, is a potent
inducer of autophagy formation.31 We ﬁrst conﬁrmed
that starvation (EBSS medium containing 1mM pepsta-
tin A and E-64-d solution, as a positive control) stimu-
lated the autophagy process in Caco2 cells (Fig. 6A).
Consistently, the ratio of LC3-II to LC3-I (hallmark of
autophagy induction) was upregulated by rapamycin
treatment (Fig. 6B and Figure S1E) or treatment with
starvation (Fig. 6C and Figure S1F). Similar to rapamycin
treatment (Fig. 3B and D), starvation also signiﬁcantly
inhibited rotavirus mRNA (Fig. 6D) and viral protein
synthesis (Fig. 6E and Figure S1G). Interestingly, induc-
tion of autophagy by rapamycin and starvation was con-
ﬁrmed to be via 4E-BP1. Because the autophagy is
equally increased by rapamycin treatment, in which
4E-BP1 is not phosphorylated at all in the mutant
(Fig. 6F). Consistently, the upregulation of LC3-II/LC3-I
ratio by rapamycin or starvation was blocked in 4E-BP1
knockout MEFs cells (¡/¡) (Fig. 6G and H).
To demonstrate the role of autophagy in rotavirus
infection, we applied RNAi knockdown of key compo-
nents of the autophagy machinery. To this aim, LC3
gene that is associated with the autophagosome mem-
brane was silenced with 10 integrating lentiviral RNAi
vectors. Five (no 10177, 10178, 10180, 10182 and 10184)
out of them showed potent knockdown (Fig. 7A). Signiﬁ-
cant increase of rotavirus genomic RNA was found in all
of the 5 knockdown Caco2 cell lines as quantiﬁed by
qRT-PCR (Fig. 7B). It was further conﬁrmed that viral
protein synthesis was increased in these 5 knockdown
Caco2 cell lines (Fig. 7C). Beclin1 plays an important
role in localization of autophagic proteins to a pre-auto-
phagosomal structure.32 Similarly, knockdown of Beclin1
also favored rotavirus infection (Fig. 7D, E and F). Of
note, the 3 optimal knockdown (no 7865, 7866 and
7867) clones were found to increase rotavirus genomic
Figure 7. Silence of autophagy related genes, LC3-II and beclin1, inhibits rotavirus replication. (A) Western blot detected LC3-II protein
in lentiviral RNAi against LC3-II transduced Caco2 cells. (B) LC3-II knockdown increased rotavirus genomic RNA determined by qRT-PCR
(n D 4–10, mean § SEM, P < 0.05, P < 0.01, Mann-Whitney test). (C) LC3-II knockdown increased rotavirus VP4 protein synthesis
detected by western blot assay. (D) Western blot detected beclin1 protein in lentiviral RNAi against beclin1 transduced Caco2 cells. (E)
Beclin1 knockdown increased rotavirus genomic RNA determined by qRT-PCR (n D 11–17, mean § SEM, P < 0.001, Mann-Whitney
test). (F) Beclin1 knockdown increased rotavirus VP4 protein synthesis detected by western blot assay.
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RNA by 27.3 § 11.9 (n D 11; P < 0.01), 12.8 § 3.0 (n D
13; P < 0.001) and 8.2 § 2.1 (n D 17; P < 0.001) fold,
respectively (Fig. 7E). The viral protein synthesis was
further conﬁrmed to be increased in Beclin1 knockdown
Caco2 cells (Fig. 7F). Thus, we conclude that 4E-BP1
mediates rapamycin-induced autophagy machinery in
inhibiting rotavirus infection.
Discussion
Many viruses interfere with or use PI3K-Akt-mTOR
pathway to regulate their infection.19 Vesicular stomatitis
virus (VSV) infection and replication have been reported
to lead to dephosphorylation and inactivation of Akt.33
In contrast, inﬂuenza A virus replication activates Akt
phosphorylation by the viral NS1 protein. It directly
binds to the PI3K regulatory subunit (p85b), allowing
the catalytic domain (p110) to phosphorylate Akt.34
Recent structural study has provided insights into the
mechanism by which NS1 activates the PI3K (P85b:
P110) holoenzyme.35 White spot syndrome virus
(WSSV) stimulates phosphorylation of 4E-BP1, the
downstream element of PI3K-Akt-mTOR pathway.36
Semliki Forest virus (SFV) and human papillomavirus
type 16 (HPV16) have also been reported to phosphory-
late the mTOR targets S6 kinase and 4E-BP1.37,38 In fact,
PI3K-Akt-mTOR pathway serves as a pro- or antiviral
double-edged sword depending on the types of viruses.
The pathway itself has been demonstrated to exert inhib-
itory effect on hepatitis E virus (HEV) replication via 4E-
BP1.13 In contrast, it is also involved in promoting the
infection of a broad-spectrum of viruses. Thus, blocking
PI3K by its inhibitor could vigorously inhibit infection of
numerous viruses including LCMV19 and coxsackievi-
rus.39 Over-expression of p70S6K or Akt stimulates
mRNA expression of coxsackievirus B3 (CVB3).40 Rota-
virus infection has been reported to activate phosphory-
lation of p70S6K in piglets.41 However, we did not found
evidence that rotavirus infection induced phosphoryla-
tion of 4E-BP1, S6, Akt or p70S6K in our system (cells of
human origin). The underlying discrepancy might derive
from the differences of the species and distinct physio-
logic situation, since animal models in some cases are of
limited relevance to human physiology.42 However, this
pathway is essential in sustaining rotavirus infection, and
inhibition of PI3K-Akt-mTOR signaling resulted in
potent anti-rotavirus activity (Figs. 1, 2, 3, 4 and 5).
PI3K-Akt-mTOR pathway functions by phosphoryla-
tion of its downstream effectors including ribosomal
protein S6 Kinase 1 (S6K1) and 4E-BP1 to upregulate
cap-dependent mRNA translation.43 Merkel cell poly-
omavirus (MCV) stirs phosphorylation of 4E-BP1. Sub-
sequently, it disassociates from eIF4E to form the eIF4F
complex to induce mRNA translation.44 Rift valley fever
virus (RVFV) induces decay of 50-TOP mRNAs via
4E-BP1 to restrict virus replication.45 We have demon-
strated that the anti-rotavirus effect by inhibition of
PI3K-Akt-mTOR pathway is predominantly via 4E-BP1
but not S6K. It has been reported that 4E-BP1 mediates
the inhibitory effect of mTOR on autophagy formation.46
In this study, we conﬁrmed that autophagy was induced
by inhibiting mTOR with treatment of rapamycin in our
system, and this process is mediated by 4E-BP1.
The process of autophagy induction has been impli-
cated in regulating many types of virus infection with
various mechanism-of-action.31,47 We have functionally
demonstrated that autophagy machinery exerts antiviral
effect against rotavirus (Fig. 6D and E). Some viruses
including human cytomegalovirus,48 hepatitis B virus-X
(HBx) 49 and chikungunya virus 50 have been reported to
lure autophagy machinery in host. Rotavirus was also
reported to induce autophagy in piglet intestine.51 How-
ever, we did not observe changed ratio of LC3-II to
LC3-I upon rotavirus infection. The key autophagy
related genes have been well studied in regulating virus
infections with different model-of-actions. During Sind-
bis virus infection, beclin 1 expression was upregulated
that may result in xenophagy (a selective autophagy) of
Sindbis virus to defend the infection.52 Several autophagy
related genes can promote both innate and adaptive
immune response to combat viral infection.53 We dem-
onstrated that silence of LC3-II and beclin1 led to potent
increase of rotavirus infection (Fig. 7).
In the clinic, organ transplantation patients irrespec-
tive to their age are very sensitive to rotavirus infection.
Long-term use of immunosuppressants is an important
risk factor causing persistent infection in these patients.4
Rapamycin as a potent mTOR inhibitor has been used as
immunosuppressant in transplant patients for decades.54
It has been well documented that different types of
immunosuppressants may differentially affect virus
infection.4,55 Antiviral effects of rapamycin have been
demonstrated in models of herpes simplex virus,56
coxsackievirus39 and HIV-1 infections.21 Our data dem-
onstrating potent anti-rotavirus effect of rapamycin
favor the clinical application of this immunosuppressant
in rotavirus-infected organ recipients.
In summary (Fig. 8), we have dissected the effects of
PI3K-Akt-mTOR signaling on rotavirus infection, and
demonstrated that blocking this pathway can potently
inhibit rotavirus replication. Importantly, the mTOR
inhibitor, rapamycin, induced autophagy machinery to
inhibit rotavirus infection via 4E-BP1. Thus, this study
revealed new insights on rotavirus-host interactions and
provided new avenues for antiviral drug development. Fur-
thermore, it provides important references for transplant
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clinicians to design optimal immunosuppression protocols
for rotavirus infected organ transplant patients.
Materials and methods
Reagents
Stocks of LY294002, an inhibitor of PI3K-Akt (Sigma-
Aldrich), BEZ235, a dual inhibitor of PI3K-Akt and
mTOR (Selleck Chemicals), rapamycin, a mTOR
inhibitor (Merk, Schiphol-Rijk, The Netherlands) and
PF-4708671, an inhibitor of p70S6K (Selleck Chemi-
cals) were dissolved in dimethyl sulfoxide (DMSO)
(Sigma-Aldrich, St Louis, MO). All reagents were
stored in 25 mL aliquots and frozen at ¡80C. Other
reagents including Earle’s Balanced Salt Solution
(EBSS) (Lonza), E-64-d (Santa Cruz Biotech, Santa
Cruz, CA) and pepstatin A (Santa Cruz Biotech,
Santa Cruz, CA) were also used.
Viruses
Simian rotavirus SA11 was used and prepared as
described previously.23 Patient-derived rotavirus isolates
were isolated from stool samples of rotavirus-infected
patients during diarrhea period as described previously.23
Cell and human primary intestinal organoid culture
Caco2 (Caucasian colon adenocarcinoma) cells are the
heterogeneous human epithelial colorectal adenocarci-
noma cells, representing numerous characteristics of enter-
ocytes. They are commonly used for in vitro modeling
rotavirus infection. Caco2 cells were maintained in culture
in T25/T75 ﬂask with Dulbecco’s modiﬁed Eagle medium
(DMEM) (Invitrogen-Gibco, Breda, The Netherlands) as
described previously.23 Immortalized mouse embryonic
ﬁbroblasts (MEFs) derived from 4E-BP1 wild-type (C/C)
and 4E-BP1 knockout (¡/¡) mice (gifts from E.N. Fish’s
laboratory) were cultured in DMEM (Invitrogen-Gibco,
Breda, The Netherlands) containing 10% vol/vol fetal calf
serum (FCS) (Hyclone, Lonan, Utah), 100 IU/mL penicil-
lin, 100 mg/mL streptomycin and 2 mM L-glutamine
(Invitrogen-Gibco).
3D cultures of human intestinal organoids were per-
formed as described previously.23 Brieﬂy, intestinal tis-
sues were vigorously shaken in 8 mM EDTA for 15 min
at 4C, followed by removing the EDTA solution. Subse-
quently loosened crypts were collected by pipetting the
solution up and down through a 10 mL pipette for
8–10 times. The crypt suspension was transferred into
a 50 mL centrifuge tube (Greiner bio-one, the
Netherlands) and biopsies were re-used for repeated col-
lection of crypts (2–3 times). Crypt suspensions were
pooled and centrifuged at 300 g for 5 min. Pelleted crypts
were re-suspended in 2 mL complete medium with
growth factors CMGF-: advanced DMEM/F12 supple-
mented with 1% (vol/vol) GlutaMAXTM Supplement
(Gibco, Grand island, USA), 10 mM HEPES, and col-
lected by centrifugation at 130 g for 5 min at 4C. Crypts
were ﬁnally suspended in Matrigel (Corning, Bedford,
USA), and placed in the center of a well of a 24-well plate
(40 mL per well). After the Matrigel had solidiﬁed
(15 min at 37C), organoids were cultured in culture
medium at 37C, 5% CO2. Culture medium was
refreshed every 2–3 days, and organoids were passaged
every 6–7 d.
TCID50 assay
Reed and Muench method was applied to determine
infectious virus titration with a standard TCID50 proto-
col by means of MA104 cells.57
Figure 8. Schematic depicting the PI3K-Akt-mTOR signaling
involved in regulating rotavirus replication. Pharmaceutical
blocking PI3K-Akt-mTOR pathway inhibits phosphorylation and
activation of its downstream targets including p70S6K and 4E-
BP1. 4E-BP1 mediates inhibition of mTOR on autophagy machin-
ery via 4E-BP1. Autophagy itself exerts anti-rotavirus effect.
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Virus infections and treatment of drugs
The protocols of inoculation of Caco2 cells with SA11
and patient-derived rotavirus were described previ-
ously.23 Brieﬂy, cell monolayers of Caco2 cells were incu-
bated with SA11 rotavirus at 37C with 5% CO2 for
60 min for infection, followed by removing free virus
particles. Subsequently, cells were added with culture
medium (FCS free) containing 5 mg/mL of trypsin and
indicative drugs, followed by incubation at 37C in a
humidiﬁed 5% CO2 incubator.
Organoids were inoculated with activated virus
(5,000 genome copies) for 60 min at 37C with 5%
CO2, followed by removing free viral particles. Then,
organoids were aliquoted in wells of a 48-well plate
coated with 20% (vol/vol) Collagen R Solution
(SERVA, Heidelberg, Germany) and culture medium
containing drugs of interest was added. Subsequently,
the 48-well plate containing organoids was spin down
at 500 g for 5 minutes to promote the adherence on
the bottom of the wells, followed by maintaining
them at 37C with 5% CO2.
Preparation of patient-derived rotavirus was per-
formed as described earlier,23 and protocols of viral
inoculation and treatment of drugs are similar to
SA11 rotavirus. 48 h post-infection was used to deter-
mine viral replication levels, since it is the optimal
time point for viral replication without lysis of the
cells.
RNA isolation, cDNA synthesis and qRT-PCR
Total RNA was extracted using a NucleoSpin RNA kit
(MACHEREY-NAGEL, D€uren, Germany) and quanti-
ﬁed with a Nanodrop ND-1000 (Wilmington, DE, USA).
500 ng of RNA was used as template for cDNA prepara-
tion with the reverse transcription system from
TAKARA (TAKARA BIO INC). Quantitative real-time
PCR (qRT-PCR) reactions were performed with SYBR
Green (Applied Biosystems, Austin, USA) according to
the manufacturer’s instruction. qRT-PCR was performed
in an IQ5 cycler PCR machine (Bio-Rad). The levels of
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA were used as an endogenous reference to normal-
ize the quantities of target mRNA by using the formula
2¡DDCT (DDCT D DCTsample-DCTcontrol). All primer
sequences were indicated in Table S1.
Gene silencing assays
Lentiviral pLKO knockdown vectors (Sigma-Aldrich)
targeting mTOR, 4E-BP1 and non-targeted control lenti-
virus were obtained from the Erasmus Biomics Center
and produced in human embryonic kidney cell-line
293T (HEK293T) cells.
Caco2 cells were transduced with lentiviral vectors to
generate stable gene knockdown cells. Transduced cells
were subsequently selected with 6 mg/mL puromycin
(Sigma). After pilot study, the shRNA vectors exerting
optimal gene knockdown were selected. Knockdown and
control Caco2 cells were incubated with rotavirus as
described in the foregoing.
Transient transfection
The plasmids including 4E-BP1-WT and 4E-BP1 5A
were transfected in 4E-BP1 knockout MEFs. Cells were
seeded in 6-well plates till »70% conﬂuence, followed by
adding 200 mL of Opti-MEM reduced serum medium
(Thermo Fisher Scientiﬁc) with 2 mg 4E-BP1-WT and
4E-BP1–5A plasmids and 6 mL Fu-GENE 6 transfection
reagent (Roche Applied Science, Inc.). Transfected cells
were incubated in complete medium for 24 h, followed
by refreshing with 100 nM rapamycin or control
medium for 48 h. The cells were analyzed by western
blot after treatment. The experiments were executed in
triplicate.
Cell lysis, SDS-PAGE and western blotting
After treatment and washing with PBS, cells in 6-well
plates were lysed with 400 mL of laemmli buffer
(20% [vol/vol] glycerol, 4% [wt/vol] SDS and
120 mM Tris-HCl, PH 6.8) containing 100 mM DTT,
and boiled for 10 min at 95C. Then, cell lysates were
subjected to SDS-PAGE, and proteins were trans-
ferred to a polyvinylidene diﬂuoride (PVDF) mem-
brane (Immobilon-FL). Subsequently, the membrane
was blocked with 2.5 mL blocking buffer and 2.5 mL
PBS containing 0.05% Tween 20 (PBS-T) for 1 hour
at room temperature. It was followed by incubation
with P-mTOR (1:1000, rabbit; cell signaling), t-mTOR
(1:1000, rabbit; cell signaling), p-Akt (1:1000, rabbit;
cell signaling), t-Akt (1:1000, rabbit; cell signaling),
p-S6 (1:1000, rabbit; cell signaling), t-S6 (1:1000, rab-
bit; cell signaling), p-4E-BP1 (1:1000, rabbit; cell
signaling), t-4E-BP1 (1:1000, rabbit; cell signaling),
LC3-I/II (1:1000, rabbit; cell signaling) and SA11
rotavirus VP4 (1:1000, HS-2, mouse monoclonal
(provided by professor Harry Greenberg, Stanford
University School of Medicine, USA) overnight in
5 mL of blocking buffer/PBST (1:1) cocktail at 4C.
After 3 more washes with PBST, the immunoreactive
bands were detected by western blot analysis and
detection of b-actin served as loading control (1:1000,
mouse monoclonal; Santa Cruz).
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Cytospin preparations and Confocal Laser Scanning
Microscopy (CLSM) for organoids
Organoids were harvested from Matrigel using cold PBS,
followed by ﬁxing in 4% paraformaldehyde in PBS at
4C for 10 min. Fixed organoids were added into the
appropriate wells of the CytoSpin II Cytocentrifuge
(Shandon Scientiﬁ Ltd, Runcorn, England), and spin
down at 1000 rpm for 2 min. The slides containing orga-
noids were rinsed in PBS-baths 3 £ 5 min, followed by
treatment with 0.1% (vol/vol) Triton-x100 for 4 min.
Then, the slides were rinsed in PBS-baths 2 £ 5 min, fol-
lowed by being incubated with milk-tween-glycine
medium (0.05% tween, 0.5% skim milk and 0.15% gly-
cine) to block background staining for 30 min. The slides
were incubated in a humidity chamber with p-S6 anti-
bodies (1:100, rabbit; cell signaling) diluted in milk-
tween-glycine medium at 4C overnight. The slides were
washed 3 £ 5 min in PBS-baths before 1 h incubation
with 1:1000 dilutions of the anti-rabbit IgG (HCL),
F(ab’)2 Fragment (Alexa Fluor 488 Conjugate)
secondary antibody. Nuclei were stained with DAPI (4,
6-diamidino-2-phenylindole; Invitrogen). Images were
detected using confocal electroscope.
Lentiviral expression of green ﬂuorescence protein
bound to LC3 and live imaging
Caco2 cells were cultured on cover slide on the bottom of
wells of a 6-well-plate with culture medium and trans-
duced with lentiviral particles carrying a construct of
TagGFP2-LC3 driven by the elongation factor-1 pro-
moter (Millipore LentiBrite) at a multiplicity of infection
(MOI) of 50 for 48 h. Then, the medium was changed
into the pharmacological treatment of indicated time
period. Live images were obtained by using confocal
electroscope.
Cytotoxicity assays in cells and organoids
The effects of chemical reagents on cell viability were
determined by MTT assay (Figure S6). Brieﬂy, Caco2
cells were seeded 1 £ 104 cells per well of a 96-well plate
and viable cells were detected at indicated time points by
adding 10 mL 5 mg/mL MTT per well, 3 h incubation at
37C and replacement of the medium by 100 mL DMSO
(Sigma). Absorbance (490 nm) was analyzed.
Intestinal organoids were embedded in Matrigel and
cultured in wells of 24-well-plate with organoids culture
medium containing relevant chemical reagents. The
effects of related chemical reagents on intestinal organo-
ids viability were determined by morphology of organo-
ids observed by light microscope (Figure S7).
Statistical analyses
All numerical results are expressed as Mean § SEM.
Statistical comparisons were analyzed by Mann-
Whitney test for the data without normal distribution
or t test for the data with normal distribution.
P-values less than 0.05 were considered to be statisti-
cally signiﬁcant. Analysis was performed using
GraphPad Prism Version 5 (GraphPad Software Inc.,
La Jolla, CA).
Abbreviations
4E-BP1 4E-binding protein 1
Akt protein kinase B
DMEM Dulbecco’s modiﬁed Eagle medium
DMSO dimethyl sulfoxide
FCS fetal calf serum
HBx hepatitis B virus-X
IRF1 interferon regulatory factor 1
LCMV lymphocytic choriomeningitis virus
MCV merkel cell polyomavirus
MEFs mouse embryonic ﬁbroblasts
MERS-CoV Middle East Respiratory Syndrome
Coronavirus
MOI multiplicity of infection
mTOR mammalian target of rapamycin
p70S6K p70S6 kinase
PI3K phosphatidylinositol 3-kinase
RVFV rift valley fever virus
SFV semliki forest virus; HEV, hepatitis E virus
WSSV white spot syndrome virus
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